Page last updated: 2024-08-23

raloxifene hydrochloride and calcitriol

raloxifene hydrochloride has been researched along with calcitriol in 19 studies

Research

Studies (19)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (10.53)	18.2507
2000's	12 (63.16)	29.6817
2010's	4 (21.05)	24.3611
2020's	1 (5.26)	2.80

Authors

Authors	Studies
Fournier, B; Häring, S; Kaye, AM; Sömjen, D	1
O'Mahony, D	1
Eisman, JA; Sambrook, PN	1
Amir-Zaltsman, Y; Knoll, E; Kohen, F; Somjen, D; Stern, N	1
Compston, JE	1
Kleerekoper, M; Schein, JR	1
Matsumoto, T	1
Braddon, J; Phillips, P	1
Hendel, D; Katzburg, S; Kaye, AM; Posner, GH; Somjen, D; Waisman, A	1
Knoll, E; Somjen, D; Stern, N; Tamir, S; Vaya, J	1
Hendel, D; Katzburg, S; Kaye, AM; Posner, GH; Somjen, D; Tamir, S; Vaya, J	1
Bleiberg, I; Kaye, AM; Ofer, M; Somjen, D	1
Somjen, D	1
Cosman, F; Glass, EV; Krege, JH; Mauck, KF; Recknor, C; Wermers, RA; Xie, L	1
Duncan, EL; Gunanti, I; Hollingworth, SA; Nissen, LM	1
Braga, S; Cannata-Andía, JB; Carrillo-López, N; Fernández-Coto, T; López-Hernández, F; Lopez-Novoa, JM; Naves-Díaz, M; Rodríguez-Rodríguez, A	1
Gayer, B; Katzburg, S; Kohen, F; Livne, E; Posner, GH; Somjen, D; Yoles, I	1
Gallagher, JC; Tella, SH	1
Aljunidee, KA; Bardaweel, SK	1

Reviews

5 review(s) available for raloxifene hydrochloride and calcitriol

Article	Year
Osteoporosis prevention and treatment. The Medical journal of Australia, 2000, Mar-06, Volume: 172, Issue:5 Topics: Alendronate; Anabolic Agents; Bone Density; Calcitriol; Calcium; Estrogen Replacement Therapy; Etidronic Acid; Evidence-Based Medicine; Female; Humans; Male; Osteoporosis; Practice Guidelines as Topic; Raloxifene Hydrochloride; Risk Factors; Treatment Outcome; Vitamin D	2000
Comparative safety of bone remodeling agents with a focus on osteoporosis therapies. Journal of clinical pharmacology, 2001, Volume: 41, Issue:3 Topics: Bone Remodeling; Calcitonin; Calcitriol; Calcium; Diphosphonates; Drug Therapy, Combination; Female; Fluorides; Hormone Replacement Therapy; Humans; Osteoporosis; Raloxifene Hydrochloride; Risk Assessment; Selective Estrogen Receptor Modulators	2001
[Osteoporosis]. Ryumachi. [Rheumatism], 2002, Volume: 42, Issue:6 Topics: Animals; Bone Resorption; Calcitriol; Clinical Trials as Topic; Diphosphonates; Humans; Osteoblasts; Osteoclasts; Osteogenesis; Osteoporosis; Parathyroid Hormone; Raloxifene Hydrochloride; Vitamin D	2002
Vitamin D modulation of the activity of estrogenic compounds in bone cells in vitro and in vivo. Critical reviews in eukaryotic gene expression, 2007, Volume: 17, Issue:2 Topics: Animals; Bone and Bones; Calcitriol; Creatine Kinase; Dihydrotestosterone; Drug Interactions; Estradiol; Estrogens; Female; Humans; In Vitro Techniques; Male; Ovariectomy; Phytoestrogens; Raloxifene Hydrochloride; Rats; Rats, Wistar; Receptors, Estrogen; RNA, Messenger; Selective Estrogen Receptor Modulators; Vitamin D	2007
Controversies in osteoporosis management: antiresorptive therapy for preventing bone loss: when to use one or two antiresorptive agents? Clinical obstetrics and gynecology, 2013, Volume: 56, Issue:4 Topics: Alendronate; Bone Density Conservation Agents; Calcitriol; Calcium, Dietary; Diphosphonates; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Humans; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride	2013

Trials

1 trial(s) available for raloxifene hydrochloride and calcitriol

Article	Year
Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: differences between stopping and continuing the antiresorptive agent. The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:10 Topics: Aged; Alendronate; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Calcium; Drug Administration Schedule; Female; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Patient Selection; Raloxifene Hydrochloride; Teriparatide; Treatment Outcome; United States; Vitamin D	2009

Article

Year

Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: differences between stopping and continuing the antiresorptive agent.

The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:10

Topics: Aged; Alendronate; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Calcium; Drug Administration Schedule; Female; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Patient Selection; Raloxifene Hydrochloride; Teriparatide; Treatment Outcome; United States; Vitamin D

2009

Other Studies

13 other study(ies) available for raloxifene hydrochloride and calcitriol

Article	Year
Stimulation of creatine kinase specific activity in human osteoblast and endometrial cells by estrogens and anti-estrogens and its modulation by calciotropic hormones. The Journal of endocrinology, 1996, Volume: 150, Issue:2 Topics: Calcitriol; Creatine Kinase; Endometrium; Estradiol; Estrogen Antagonists; Female; Humans; Osteoblasts; Piperidines; Plasmids; Polyunsaturated Alkamides; Raloxifene Hydrochloride; Recombinant Proteins; Stimulation, Chemical; Tamoxifen; Teriparatide; Tumor Cells, Cultured	1996
Prevention of corticosteroid-induced osteoporosis and fractures. Journal of clinical pharmacy and therapeutics, 1999, Volume: 24, Issue:2 Topics: Adrenal Cortex Hormones; Bone Density; Calcitonin; Calcitriol; Calcium Channel Agonists; Estrogen Antagonists; Fractures, Bone; Hormone Replacement Therapy; Humans; Osteoporosis; Piperidines; Raloxifene Hydrochloride	1999
Vitamin D analogs modulate the action of gonadal steroids in human vascular cells in vitro. American journal of hypertension, 2000, Volume: 13, Issue:4 Pt 1 Topics: Androgens; Antibodies; Antineoplastic Agents; Blotting, Western; Calcitriol; Creatine Kinase; DNA; Endothelium, Vascular; Estradiol; Estrogen Antagonists; Humans; In Vitro Techniques; Muscle, Smooth, Vascular; Raloxifene Hydrochloride; Receptors, Estrogen; Thymidine; Tritium; Umbilical Arteries; Umbilical Veins	2000
Pharmacological interventions for the prevention of vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: does site-specificity exist? Bone, 2000, Volume: 27, Issue:6 Topics: Aged; Alendronate; Calcitriol; Calcium Channel Agonists; Calcium Channel Blockers; Estrogen Antagonists; Etidronic Acid; Female; Hip Fractures; Humans; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risedronic Acid; Spinal Fractures	2000
Osteoporosis--diagnosis, treatment and management. Australian family physician, 2004, Volume: 33, Issue:3 Topics: Aged; Calcitriol; Diphosphonates; Disease Progression; Evidence-Based Medicine; Female; Humans; Life Style; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk Factors	2004
Treatment with non-hypercalcemic analogs of 1,25-dihydroxyvitamin D3 increases responsiveness to 17beta-estradiol, dihydrotestosterone or raloxifene in primary human osteoblasts. The Journal of steroid biochemistry and molecular biology, 2004, Volume: 88, Issue:2 Topics: Calcitriol; Creatine Kinase; Dihydrotestosterone; Estradiol; Female; Humans; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators	2004
Estrogen-like activity of licorice root constituents: glabridin and glabrene, in vascular tissues in vitro and in vivo. The Journal of steroid biochemistry and molecular biology, 2004, Volume: 91, Issue:3 Topics: Animals; Calcitriol; Cells, Cultured; Creatine Kinase; DNA Replication; Endothelium, Vascular; Estrogens; Female; Glycyrrhiza; In Vitro Techniques; Isoflavones; Male; Ovariectomy; Phenols; Plant Roots; Raloxifene Hydrochloride; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators	2004
Estrogenic activity of glabridin and glabrene from licorice roots on human osteoblasts and prepubertal rat skeletal tissues. The Journal of steroid biochemistry and molecular biology, 2004, Volume: 91, Issue:4-5 Topics: Animals; Calcitriol; Creatine Kinase; Drug Combinations; Estrogens; Female; Glycyrrhiza; Growth Plate; Humans; Isoflavones; Osteoblasts; Ovariectomy; Phenols; Plant Roots; Postmenopause; Premenopause; Raloxifene Hydrochloride; Rats; Rats, Wistar; Vitamin D	2004
The role of non-calcemic analogs of vitamin D in differentiation of cultured rat bone marrow into osteoblast-like cells: age and sex differences. Journal of endocrinological investigation, 2005, Volume: 28, Issue:10 Topics: Aging; Alkaline Phosphatase; Animals; Bone Marrow Cells; Calcitriol; Cell Differentiation; Cells, Cultured; Creatine Kinase; Dexamethasone; Dihydrotestosterone; Estradiol; Female; Male; Orchiectomy; Osteoblasts; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Inbred WKY; Sex Characteristics	2005
Secondary prevention of osteoporosis in Australia: analysis of government-dispensed prescription data. Drugs & aging, 2010, Mar-01, Volume: 27, Issue:3 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Australia; Bone Density Conservation Agents; Calcitriol; Calcium Carbonate; Calcium Citrate; Diphosphonates; Drug Administration Schedule; Drug Utilization; Female; Humans; Male; Osteoporosis; Raloxifene Hydrochloride; Sex Factors	2010
Differential effects of 17beta-estradiol and raloxifene on bone and lipid metabolism in rats with chronic kidney disease and estrogen insufficiency. Menopause (New York, N.Y.), 2010, Volume: 17, Issue:4 Topics: Animals; Atrophy; Bone Density Conservation Agents; Calcitriol; Calcium; Cholesterol; Chronic Disease; Estradiol; Estrogens; Female; Hyperplasia; Kidney Diseases; Mammary Glands, Animal; Organ Size; Parathyroid Hormone; Phosphorus; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Tibia; Uterus	2010
The effects of native and synthetic estrogenic compounds as well as vitamin D less-calcemic analogs on adipocytes content in rat bone marrow. Journal of endocrinological investigation, 2011, Volume: 34, Issue:2 Topics: Adipocytes; Animals; Bone Marrow Cells; Calcitriol; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Genistein; Isoflavones; Ovariectomy; Phytoestrogens; Raloxifene Hydrochloride; Rats; Rats, Wistar	2011
Combination therapy of calcitriol inhibits the proliferation of breast cancer cells: new concept of nonclassical function of calcitriol. Hormone molecular biology and clinical investigation, 2021, Nov-15, Volume: 43, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Calcitriol; Cell Line, Tumor; Cell Proliferation; Female; Humans; MCF-7 Cells; Raloxifene Hydrochloride	2021